“Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s428. Accessed May 19, 2025. https://skin.dermsquared.com/skin/article/view/3105.